歐洲的整形外科生醫材料市場:2012年

歐洲的整形外科生醫材料市場:2012年 是由出版商Millennium Research Group在2011年12月所出版的。 這份英文市場調查報告書價格從美金6995起跳。

簡介

本報告提供歐洲的整形外科生醫材料市場現況與展望調查分析，治療種類與概要，各國市場背景，主要產品的功能·特徵，新產品概要，臨床實驗趨勢，領導品牌的競爭環境與市場佔有率，各國與各類產品的市場成長預測(∼2016年)等彙整資料，為您概述為以下內容。

摘要整理

第1章 臨床環境

• 背景
• 治療概要
  • 骨頭移植術
  • 玻尿酸關節內替代療法
  • 膝關節軟骨修復的競爭治療
  • 新的競爭治療·技術
• 各國概要
  • 法國
  • 德國
  • 義大利
  • 西班牙
  • 英國
    • 人口統計與經濟
    • 醫療制度
    • 法律制度
  • EU尖端醫療醫藥品(ATMP)的標準化
  • 製造·流通

第2章 產品

• 概要
• 骨移植片
• 玻尿酸關節內補充產品
• 膝關節軟骨修復產品
  • 功能
  • 新的產品等

第3章 臨床實驗

• 完成的臨床實驗
• 持續中的臨床實驗

第4章 品牌及競爭分析

• 概要
• 人工骨替代材料市場
• 玻尿酸關節內補充市場
• 膝關節軟骨修復市場
  • 競爭概要
  • 更多的競爭環境
  • 市場佔有率
  • 近幾年的事項等

第5章 整形外科生醫材料市場預測

• 市場概要

第6章 人工骨替代材料市場預測

• 市場概要
• 詳細內容市場概要
  • 各材料
  • 手術各類型
• 法國
• 德國
• 義大利
• 西班牙
• 英國

第7章 玻尿酸關節內補充市場預測

• 市場概要
• 詳細內容市場概要
• 法國
• 德國
• 義大利
• 西班牙
• 英國

第8章 膝關節軟骨修復市場預測

• 市場概要
• 詳細內容市場概要
  • 清創手術·微創(只有手術)
  • 自體軟骨細胞移植術
  • 單步技術
  • 自體軟骨移植術
  • 異體骨軟骨移植術
  • 合成移植片
• 法國
• 德國
• 義大利
• 西班牙
• 英國

附錄

圖表

目錄

The European orthopedic biomaterial market will experience moderate growth over the forecast period, driven primarily by the aging European population, increasing marketing efforts by manufacturers and distributors to educate both physicians and patients on the wide variety of biomaterials available, as well as ongoing innovation by both domestic and international companies. Economic challenges will, however, continue to hinder market growth, notably in the hyaluronic acid (HA) viscosupplementation and knee cartilage repair markets, where the procedures are elective and patients are more likely to delay treatment when personal spending decreases. Furthermore, poor reimbursement will continue to inhibit market expansion as many European governments curb health care spending and favor the use of less expensive materials. Nevertheless, patients and physicians will continue to trend toward treatments that provide greater convenience, such as 1-injection HA viscosupplementation, or offer less painful procedures, such as bone graft substitutes (BGS). As a result, the European orthopedic biomaterial market will continue to show sustained growth throughout the forecast period.

This report uses a number of methodologies to gather and present data and analysis. At the outset, a large survey of secondary sources is conducted. These sources act as the basis for the primary research stage, which builds and enhances the quantitative and qualitative attributes of the early research.

Secondary sources include

• Government sources:
  • Securities and Exchange Commission filings
  • Food and Drug Administration and patent filings
  • National Center for Health Statistics data
  • National Institute for Health and Clinical Excellence
  • L'Agence Francaise de Securite Sanitaire des Produits de Sante
  • US Census Bureau International Database
  • European Medicines Agency
• Orthopedic biomaterial companies:
  • Annual reports, product brochures, corporate profiles, etc.
• Internal databases and reports:
  • Previous reports on similar/related sources
• General Internet searches, medical literature, and newspaper/magazine searches:
  • Identifying various centers of specialization and articles that might provide leads for primary research

The secondary research stage builds the foundation for the primary research.

Step 1: The first step involves an impartial scan of all the information gathered during the secondary research stage to determine its utility based on the specific requirements of this report. Each piece of information is either discarded or marked as high- or low-priority and then organized appropriately as determined by the structure and sectioning of the report.

Step 2: At this stage, early assumptions are formed as to the implications of the information for the various orthopedic biomaterial market segments. These assumptions are then used to determine hypotheses using both inductive and deductive approaches. On the quantitative front, these hypotheses result in full historical and projected market data sets (market sizes - unit sales, average selling prices [ASPs], and revenues - as well as market shares).

Step 3: At this stage, the research is in position for its most important primary phase - expert interviews. Throughout the secondary research phase, industry and medical experts are identified.

These experts are then contacted by telephone and asked to participate in interviews on recent trends and developments in the industry. Interviews are either conducted at the time of the initial call or scheduled at the convenience of the expert. Interview questions are tailored to the expertise of each particular interviewee, although in most cases, the most important questions are asked of all experts.

The questions are largely based on the assumptions and hypotheses developed in Step 2, which are then augmented, discarded, or adjusted based on the views and positions put forth. Attempts are made, whenever possible, to cross-check the views of various experts against each other and to reach positions of consensus on issues and market numbers.

Step 4: The final stage of primary research involves individual and group analysis by Millennium Research Group. All research results are assessed and cross-checked thoroughly to determine their validity, relevance, and weight. From this process, qualitative conclusions are reached and data points finalized.

In addition to the research methodology outlined above, the following “bottom-up” methodology is used to develop forecast assumptions for the report.

A comprehensive breakdown of various orthopedic biomaterial procedures and unit sales is prepared using data from several sources, including professional associations, government statistics, and private research/media sources. Industry experts and practitioners are consulted to ensure accuracy and verify observed trends. As a cross-check, total industry revenues available through annual reports and other sources are compared against modeled industry revenues.

Using the best estimates of industry experts, practitioners, private research/media sources, and inhouse experts, year-by-year growth rates and ASPs are applied individually to each subcategory to derive forecasts. These estimates are cross-checked by industry experts (marketing managers, product managers, CEOs, etc.) and further refined.

Overall findings are compared against market and procedure forecasts published by other sources to ensure reasonable estimates.

Companies mentioned in this report:

• Aesculap (a division of B. Braun)
• AorTech International
• Anika Therapeutics
• ApaTech (acquired by Baxter)
• Arthrex
• Arthro Kinetics
• Athersys
• Berkeley Advanced Biomaterials
• Biocomposites
• Biomatlante
• Biomet
• BioMimetic Therapeutics
• Bioniche Pharma
• BioSyntech
• Bioteck
• BioTissue
• Carticept Medical
• Ceramisys
• Cerapedics
• CERAVER
• co.don
• Croma-Pharma
• curasan
• DePuy
• Documedica
• Exactech
• Ferring Pharmaceuticals
• FH ORTHOPEDICS
• Fidia Advanced Biopolymers (acquired by Anika Therapeutics)
• Fidia Farmaceutici
• Finceramica
• Geistlich
• Genzyme Biosurgery (acquired by Sanofi)
• Integra LifeSciences
• INOTEB
• ISYS/Biovation
• Kasios
• Kensey Nash
• Kyungwon Medical
• Laboratoires Genevrier
• Laboratoires Pierre Fabre
• LCA Pharmaceutical
• Lifecore Biomedical
• Mathys Orthopaedics
• Matricel
• MBA Grupo
• Medtronic Spinal & Biologics
• Merckle Recordati
• Millenium Biologix
• NovaBone Products
• NuVasive
• Olympus Biotech
• ORMED.DJO
• Orthogen
• Orthovita (acquired by Stryker in June 2011)
• OSSACUR
• Osteotech
• Oswestry
• Q-Med
• Regenerative Medical Services
• Rottapharm-Madaus
• RTI Biologics
• SaluMedica
• Science & Bio Materials (SBM)
• Scient'x (acquired by Alphatec Spine)
• Seikagaku
• SIGNUS Medizintechnik
• Smith & Nephew
• Stryker
• Synthes
• Tecnoss Dental
• Tedec-Meiji Farma
• TEKNIMED
• TiGenix
• TRB Chemedica
• Wright Medical Technology
• Zimmer

TABLE OF CONTENTS

LIST OF FIGURES AND TABLES

EXECUTIVE SUMMARY

1.0. CLINICAL LANDSCAPE

• 1.1. Background
  • 1.1.1. Osteoarthritis
  • 1.1.2. Knee Cartilage Injuries
• 1.2. Procedure Overview
  • 1.2.1. Bone Graft Procedures
    • 1.2.1.1. Trauma Surgeries
    • 1.2.1.2. Large-Joint Revision and Reconstruction Procedures
    • 1.2.1.3. Thoracolumbar and Cervical Spinal Fusions
    • 1.2.1.4. Craniomaxillofacial Surgeries
    • 1.2.1.5. Extremity Surgeries
  • 1.2.2. Hyaluronic Acid Viscosupplementation Treatments
  • 1.2.3. Knee Cartilage Repairs
    • 1.2.3.1. Debridement and Microfracture
    • 1.2.3.2. Osteochondral Autograft Transplantation
    • 1.2.3.3. Osteochondral Allograft Transplantation
    • 1.2.3.4. Autologous Chondrocyte Implantation
    • 1.2.3.5. Single-Step Technologies
    • 1.2.3.6. Synthetic Implants
  • 1.2.4. Competing Treatments
  • 1.2.5. Emerging Competing Treatments and Technologies
• 1.3. Country Overviews
  • 1.3.1. France
    • 1.3.1.1. Demographics and Economy
    • 1.3.1.2. Health Care System
    • 1.3.1.3. Regulatory Environment
  • 1.3.2. Germany
    • 1.3.2.1. Demographics and Economy
    • 1.3.2.2. Health Care System
    • 1.3.2.3. Regulatory Environment
  • 1.3.3. Italy
    • 1.3.3.1. Demographics and Economy
    • 1.3.3.2. Health Care System
    • 1.3.3.3. Regulatory Environment
  • 1.3.4. Spain
    • 1.3.4.1. Demographics and Economy
    • 1.3.4.2. Health Care System
    • 1.3.4.3. Regulatory Environment
  • 1.3.5. UK
    • 1.3.5.1. Demographics and Economy
    • 1.3.5.2. Health Care System
    • 1.3.5.3. Regulatory Environment
  • 1.3.6. Standardization of Advanced Medical Therapy Medicinal Products in the European Union
  • 1.3.7. Manufacturing and Distribution

2.0. PRODUCTS

• 2.1. Overview
  • 2.1.1. Products Covered
• 2.2. Bone Grafts
  • 2.2.1. Functions
    • 2.2.1.1. Autografts
    • 2.2.1.2. Growth Factors
    • 2.2.1.3. Demineralized Bone Matrices
    • 2.2.1.4. Synthetics
    • 2.2.1.5. Nonproprietary Allografts
    • 2.2.1.6. Xenografts
  • 2.2.2. Differentiating Features
  • 2.2.3. Emerging Products
• 2.3. Hyaluronic Acid Viscosupplementation Products
  • 2.3.1. Functions
  • 2.3.2. Differentiating Features
  • 2.3.3. Emerging Products
• 2.4. Knee Cartilage Repair Products
  • 2.4.1. Functions
  • 2.4.2. Emerging Products
    • DePuy's Cartilage Autograft Implantation System
    • TiGenix's ChondroCelect
    • BioSyntech's BST-CarGel

3.0. CLINICAL TRIALS

• 3.1. Completed Clinical Trials
• 3.2. Ongoing Clinical Trials

4.0. BRANDS AND COMPETITIVE ANALYSIS

• 4.1. Overview
  • 4.1.1. Competitive Snapshot
  • 4.1.2. Market Shares
  • 4.1.3. Recent Events
• 4.2. Bone Graft Substitute Market
  • 4.2.1. Competitive Snapshot
  • 4.2.2. Detailed Competitive Landscape
  • 4.2.3. Current Market Shares
  • 4.2.4. Recent Events
• 4.3. Hyaluronic Acid Viscosupplementation Market
  • 4.3.1. Competitive Snapshot
  • 4.3.2. Detailed Competitive Landscape
  • 4.3.3. Current Market Shares
  • 4.3.4. Recent Events
• 4.4. Knee Cartilage Repair Market
  • 4.4.1. Competitive Snapshot
  • 4.4.2. Detailed Competitive Landscape
  • 4.4.3. Current Market Shares

5.0. ORTHOPEDIC BIOMATERIAL MARKET OUTLOOK

• 5.1. Market Snapshot
• 5.2. Market Overview

6.0. BONE GRAFT SUBSTITUTE MARKET OUTLOOK

• 6.1. Market Snapshot
• 6.2. Detailed Market Overview
  • 6.2.1. Market Overview By Material
    • 6.2.1.1. Autografts (Procedures Only)
    • 6.2.1.2. Synthetics Market
    • 6.2.1.3. Demineralized Bone Matrix Market
    • 6.2.1.4. Growth Factor Market
    • 6.2.1.5. Xenograft Market
    • 6.2.1.6. Nonproprietary Allograft Market
  • 6.2.2. Market Overview By Procedure Type
    • 6.2.2.1. Trauma Surgery Bone Graft Substitute Market
    • 6.2.2.2. Large-Joint Revision and Reconstruction Bone Graft Substitute Market
    • 6.2.2.3. Spinal Fusion Bone Graft Substitute Market
    • 6.2.2.4. Extremity Surgery Bone Graft Substitute Market
    • 6.2.2.5. Craniomaxillofacial Surgeries Bone Graft Substitute Market
• 6.3. French Bone Graft Substitute Market Outlook
• 6.4. German Bone Graft Substitute Market Outlook
• 6.5. Italian Bone Graft Substitute Market Outlook
• 6.6. Spanish Bone Graft Substitute Market Outlook
• 6.7. UK Bone Graft Substitute Market Outlook

7.0. HYALURONIC ACID VISCOSUPPLEMENTATION MARKET OUTLOOK

• 7.1. Market Snapshot
• 7.2. Detailed Market Overview
• 7.3. French Hyaluronic Viscosupplementation Market Outlook
• 7.4. German Hyaluronic Viscosupplementation Market Outlook
• 7.5. Italian Hyaluronic Viscosupplementation Market Outlook
• 7.6. Spanish Hyaluronic Viscosupplementation Market Outlook
• 7.7. UK Hyaluronic Viscosupplementation Market Outlook

8.0. KNEE CARTILAGE REPAIR MARKET OUTLOOK

• 8.1. Market Snapshot
• 8.2. Detailed Market Overview
  • 8.2.1. Debridement and Microfracture (Procedure Only)
  • 8.2.2. Autologous Chondrocyte Implantation Market
  • 8.2.3. Single-Step Technology Market
  • 8.2.4. Osteochondral Autograft Market
  • 8.2.5. Osteochondral Allograft Market
  • 8.2.6. Synthetic Implant Market
• 8.3. French Knee Cartilage Repair Market Outlook
• 8.4. German Knee Cartilage Repair Market Outlook
• 8.5. Italian Knee Cartilage Repair Market Outlook
• 8.6. Spanish Knee Cartilage Repair Market Outlook
• 8.7. UK Knee Cartilage Repair Market Outlook

APPENDIX A: METHODOLOGY

APPENDIX B: MRG ACRONYMS AND INITIALISMS

APPENDIX C: BIBLIOGRAPHY

TABLE OF CONTENTS

LIST OF FIGURES AND TABLES

EXECUTIVE SUMMARY

• Figure 1: Orthopedic Biomaterial Market, by Country, Europe (US$), 2010 - 2016
• Table 1: Orthopedic Biomaterial Market Landscape, Europe (US$), 2011 and 2016
• Table 2: Orthopedic Biomaterial Market Leaders, by Product Type and Revenue, Europe, 2011
• Table 3: Most Promising Emerging Technologies in the Orthopedic Biomaterial Market, Europe, 2011 - 2016
• Table 4: Expected Key Events in the Orthopedic Biomaterial Market, Europe, 2012 - 2016
• Table 5: Factors Impacting the Orthopedic Biomaterial Market, by Product Type, Europe, 2011 - 2016
• Table 6: Companies Mentioned in This Report
• Table 7: Key Report Updates, 2012

1.0 CLINICAL LANDSCAPE

• Table 8: Key Health and Economic Indicators, France, 2011
• Table 9: Key Health and Economic Indicators, Germany, 2011
• Table 10: Key Health and Economic Indicators, Italy, 2011
• Table 11: Key Health and Economic Indicators, Spain, 2011
• Table 12: Key Health and Economic Indicators, UK, 2011

2.0 PRODUCTS

• Table 13: Orthopedic Biomaterial Market, by Product Type, Europe
• Table 14: Characteristics of Bone Grafts, by Material
• Table 15: Select First-Generation Synthetic BGS Materials, by Material
• Table 16: Advantages and Disadvantages of Bone Grafts, by Material
• Table 17: Emerging Products for the BGS Market, Europe, 2011 - 2016
• Table 18: Advantages and Disadvantages of HA Viscosupplementation Products, by Number of Injections
• Table 19: Knee Cartilage Repair Products, by Product Type

3.0 CLINICAL TRIALS

• Table 20: Summary of Promoting Fusion in Minimally Invasive Lumbar Interbody Stabilization with Low-Dose BMP-2 - But What is the Cost?
• Table 21: Summary of STAR
• Table 22: Summary of Efficacy of Intra-articular Hyaluronic Acid in the Knee Osteoarthritis
• Table 23: Summary of Different Volumes of DUROLANE in Knee OA
• Table 24: Summary of Intra-articular Injection of HA in Symptomatic Osteoarthritis of the Hip
• Table 25: Summary of Efficacy and Safety of 3 Different Dosage Regimens of Hyaluronic Acid in Patients with Knee Osteoarthritis (OA)
• Table 26: Summary of EVOKE
• Table 27: Efficacy and Safety of Accell Evo3 DBM in Instrumented Posterolateral Lumbar Spine Fusion
• Table 28: Summary of An Assessment of P-15 Bone Putty in Anterior Cervical Fusion With Instrumentation
• Table 29: Summary of APPRAISET1
• Table 30: Summary of INFUSE Bone Graft/PEEK Interbody Spacer/Anterior Cervical Plate Pivotal Clinical Trial (ACDF)
• Table 31: Summary of Comparing Synthetic Bone Alone Versus Synthetic Bone With Bone Marrow in Bone Lesions
• Table 32: Summary of CAIS for the Repair of Knee Cartilage Through Cartilage Regeneration

4.0 BRANDS AND COMPETITIVE ANALYSIS

• Table 33: Leading Competitors in the Orthopedic Biomaterial Market, by Product Type, as a % of Total, Europe, 2011
• Table 34: Recent Events in the Orthopedic Biomaterial Market, Europe
• Table 35: Leading Competitors in the BGS Market, by Country, as a % of Total, Europe, 2011
• Table 36: Recent Events in the BGS Market, Europe
• Table 37: Leading Competitors in the HA Viscosupplementation Market, by Country, as a % of Total, Europe, 2011
• Table 38: Recent Events in the HA Viscosupplementation Market, Europe
• Table 39: Leading Competitors in the Knee Cartilage Repair Market, by Country, as a % of Total, Europe, 2011

5.0 ORTHOPEDIC BIOMATERIAL MARKET OUTLOOK

• Figure 2: Orthopedic Biomaterial Market, by Product Type, Europe (US$), 2010 - 2016
• Table 40: Factors Impacting the Orthopedic Biomaterial Market, by Product Type, Europe, 2011 - 2016
• Table 41: Orthopedic Biomaterial Market, by Country, Europe (US$, € , and £), 2010 - 2016
• Table 42: Orthopedic Biomaterial Market, by Product Type, Europe (US$ and € ), 2010 - 2016

6.0 BONE GRAFT SUBSTITUTE MARKET OUTLOOK

• Figure 3: BGS Procedures, by Material, Europe, 2010 - 2016
• Table 43: Factors Impacting the BGS Market, Europe, 2011 - 2016
• Table 44: Average Volume of Bone Graft Used per Procedure, by Procedure Type, Europe, 2011
• Table 45: Bone Graft Procedures, by Country, Europe, 2010 - 2016
• Table 46: BGS Procedures, by Country, Europe, 2010 - 2016
• Table 47: Bone Graft Procedures, by Material, Europe, 2010 - 2016
• Table 48: Bone Graft Procedures, by Procedure Type, Europe, 2010 - 2016
• Table 49: BGS Procedures, by Procedure Type, Europe, 2010 - 2016
• Table 50: BGS Market, by Country, Europe (US$, € , and £), 2010 - 2016
• Table 51: BGS Market, by Material, Europe (US$ and € ), 2010 - 2016
• Table 52: BGS Market, by Procedure Type, Europe (US$ and € ), 2010 - 2016
• Table 53: Bone Graft Procedures, by Material, France, 2010 - 2016
• Table 54: Bone Graft Procedures, by Procedure Type, France, 2010 - 2016
• Table 55: BGS Procedures, by Procedure Type, France, 2010 - 2016
• Table 56: BGS ASPs, by Material, France (US$ and € ), 2010 - 2016
• Table 57: BGS Market, by Material, France (US$ and € ), 2010 - 2016
• Table 58: BGS ASPs, by Procedure Type, France (US$ and € ), 2010 - 2016
• Table 59: BGS Market, by Procedure Type, France (US$ and € ), 2010 - 2016
• Table 60: Bone Graft Procedures, by Material, Germany, 2010 - 2016
• Table 61: Bone Graft Procedures, by Procedure Type, Germany, 2010 - 2016
• Table 62: BGS Procedures, by Procedure Type, Germany, 2010 - 2016
• Table 63: BGS ASPs, by Material, Germany (US$ and € ), 2010 - 2016
• Table 64: BGS Market, by Material, Germany (US$ and € ), 2010 - 2016
• Table 65: BGS ASPs, by Procedure Type, Germany (US$ and € ), 2010 - 2016
• Table 66: BGS Market, by Procedure Type, Germany (US$ and € ), 2010 - 2016
• Table 67: Bone Graft Procedures, by Material, Italy, 2010 - 2016
• Table 68: Bone Graft Procedures, by Procedure Type, Italy, 2010 - 2016
• Table 69: BGS Procedures, by Procedure Type, Italy, 2010 - 2016
• Table 70: BGS ASPs, by Material, Italy (US$ and € ), 2010 - 2016
• Table 71: BGS Market, by Material, Italy (US$ and € ), 2010 - 2016
• Table 72: BGS ASPs, by Procedure Type, Italy (US$ and € ), 2010 - 2016
• Table 73: BGS Market, by Procedure Type, Italy (US$ and € ), 2010 - 2016
• Table 74: Bone Graft Procedures, by Material, Spain, 2010 - 2016
• Table 75: Bone Graft Procedures, by Procedure Type, Spain, 2010 - 2016
• Table 76: BGS Procedures, by Procedure Type, Spain, 2010 - 2016
• Table 77: BGS ASPs, by Material, Spain (US$ and € ), 2010 - 2016
• Table 78: BGS Market, by Material, Spain (US$ and € ), 2010 - 2016
• Table 79: BGS ASPs, by Procedure Type, Spain (US$ and € ), 2010 - 2016
• Table 80: BGS Market, by Procedure Type, Spain (US$ and € ), 2010 - 2016
• Table 81: Bone Graft Procedures, by Material, UK, 2010 - 2016
• Table 82: Bone Graft Procedures, by Procedure Type, UK, 2010 - 2016
• Table 83: BGS Procedures, by Procedure Type, UK, 2010 - 2016
• Table 84: BGS ASPs, by Material, UK (US$, € , and £), 2010 - 2016
• Table 85: BGS Market, by Material, UK (US$, € , and £), 2010 - 2016
• Table 86: BGS ASPs, by Procedure Type, UK (US$, € , and £), 2010 - 2016
• Table 87: BGS Market, by Procedure Type, UK (US$, € , and £), 2010 - 2016

7.0 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET OUTLOOK

• Figure 4: HA Viscosupplementation Treatments, by Number of Injections, as a % of Total, Europe, 2011 and 2016
• Table 88: Factors Impacting the HA Viscosupplementation Market, Europe, 2011 - 2016
• Table 89: HA Viscosupplementation Treatments, by Country, Europe, 2010 - 2016
• Table 90: HA Viscosupplementation Treatments and Injections, by Number of Injections, Europe, 2010 - 2016
• Table 91: HA Viscosupplementation Treatments, by Anatomy, Europe, 2010 - 2016
• Table 92: HA Viscosupplementation Market, by County, Europe (US$, € , and £), 2010 - 2016
• Table 93: HA Viscosupplementation Market, by Number of Injections, Europe (US$), 2010 - 2016
• Table 94: HA Viscosupplementation Market, by Number of Injections, Europe (€ ), 2010 - 2016
• Table 95: HA Viscosupplementation Market Growth, by Number of Injections, Europe, 2011 - 2016
• Table 96: HA Viscosupplementation Market, by Number of Injections, as a % of Total, Europe, 2010 - 2016
• Table 97: HA Viscosupplementation Treatments and Injections, by Number of Injections, France, 2010 - 2016
• Table 98: HA Viscosupplementation Treatments, by Anatomy, France, 2010 - 2016
• Table 99: HA Viscosupplementation Market, by Number of Injections, France (US$), 2010 - 2016
• Table 100: HA Viscosupplementation Market, by Number of Injections, France (€ ), 2010 - 2016
• Table 101: HA Viscosupplementation Market Growth, by Number of Injections, France, 2011 - 2016
• Table 102: HA Viscosupplementation Market, by Number of Injections, as a % of Total, France, 2010 - 2016
• Table 103: HA Viscosupplementation Treatments and Injections, by Number of Injections, Germany, 2010 - 2016
• Table 104: HA Viscosupplementation Treatments, by Anatomy, Germany, 2010 - 2016
• Table 105: HA Viscosupplementation Market, by Number of Injections, Germany (US$), 2010 - 2016
• Table 106: HA Viscosupplementation Market, by Number of Injections, Germany (€ ), 2010 - 2016
• Table 107: HA Viscosupplementation Market Growth, by Number of Injections, Germany, 2011 - 2016
• Table 108: HA Viscosupplementation Market, by Number of Injections, as a % of Total, Germany, 2010 - 2016
• Table 109: HA Viscosupplementation Treatments and Injections, by Number of Injections, Italy, 2010 - 2016
• Table 110: HA Viscosupplementation Treatments, by Anatomy, Italy, 2010 - 2016
• Table 111: HA Viscosupplementation Market, by Number of Injections, Italy (US$), 2010 - 2016
• Table 112: HA Viscosupplementation Market, by Number of Injections, Italy (€ ), 2010 - 2016
• Table 113: HA Viscosupplementation Market Growth, by Number of Injections, Italy, 2011 - 2016
• Table 114: HA Viscosupplementation Market, by Number of Injections, as a % of Total, Italy, 2010 - 2016
• Table 115: HA Viscosupplementation Treatments and Injections, by Number of Injections, Spain, 2010 - 2016
• Table 116: HA Viscosupplementation Treatments, by Anatomy, Spain, 2010 - 2016
• Table 117: HA Viscosupplementation Market, by Number of Injections, Spain (US$), 2010 - 2016
• Table 118: HA Viscosupplementation Market, by Number of Injections, Spain (€ ), 2010 - 2016
• Table 119: HA Viscosupplementation Market Growth, by Number of Injections, Spain, 2011 - 2016
• Table 120: HA Viscosupplementation Market, by Number of Injections, as a % of Total, Spain, 2010 - 2016
• Table 121: HA Viscosupplementation Treatments and Injections, by Number of Injections, UK, 2010 - 2016
• Table 122: HA Viscosupplementation Treatments, by Anatomy, UK, 2010 - 2016
• Table 123: HA Viscosupplementation Market, by Number of Injections, UK (US$), 2010 - 2016
• Table 124: HA Viscosupplementation Market, by Number of Injections, UK (€ ), 2010 - 2016
• Table 125: HA Viscosupplementation Market, by Number of Injections, UK (£), 2010 - 2016
• Table 126: HA Viscosupplementation Market Growth, by Number of Injections, UK, 2011 - 2016
• Table 127: HA Viscosupplementation Market, by Number of Injections, as a % of Total, UK, 2010 - 2016

KNEE CARTILAGE REPAIR MARKET OUTLOOK

• Figure 5: Knee Cartilage Repair Market, by Procedure Type, Europe (US$), 2010 - 2016
• Table 128: Factors Impacting the Knee Cartilage Repair Market, by Product Type, Europe, 2011 - 2016
• Table 129: Knee Cartilage Repairs, by Country, Europe, 2010 - 2016
• Table 130: Knee Cartilage Repairs, by Procedure Type, Europe, 2010 - 2016
• Table 131: Knee Cartilage Repair Market, by Country, Europe (US$, € , and £), 2010 - 2016
• Table 132: Knee Cartilage Repair Market, by Procedure Type, Europe (US$), 2010 - 2016
• Table 133: Knee Cartilage Repair Market, by Procedure Type, Europe (€ ), 2010 - 2016
• Table 134: Knee Cartilage Repair Market Growth, by Procedure Type, Europe, 2011 - 2016
• Table 135: Knee Cartilage Repair Market, by Procedure Type, as a % of Total, Europe, 2010 - 2016
• Table 136: Knee Cartilage Repairs, by Procedure Type, France, 2010 - 2016
• Table 137: Knee Cartilage Repair Market, by Procedure Type, France (US$), 2010 - 2016
• Table 138: Knee Cartilage Repair Market, by Procedure Type, France (€ ), 2010 - 2016
• Table 139: Knee Cartilage Repair Market Growth, by Procedure Type, France, 2011 - 2016
• Table 140: Knee Cartilage Repair Market, by Procedure Type, as a % of Total, France, 2010 - 2016
• Table 141: Knee Cartilage Repairs, by Procedure Type, Germany, 2010 - 2016
• Table 142: Knee Cartilage Repair Market, by Procedure Type, Germany (US$), 2010 - 2016
• Table 143: Knee Cartilage Repair Market, by Procedure Type, Germany (€ ), 2010 - 2016
• Table 144: Knee Cartilage Repair Market Growth, by Procedure Type, Germany, 2011 - 2016
• Table 145: Knee Cartilage Repair Market, by Procedure Type, as a % of Total, Germany, 2010 - 2016
• Table 146: Knee Cartilage Repairs, by Procedure Type, Italy, 2010 - 2016
• Table 147: Knee Cartilage Repair Market, by Procedure Type, Italy (US$), 2010 - 2016
• Table 148: Knee Cartilage Repair Market, by Procedure Type, Italy (€ ), 2010 - 2016
• Table 149: Knee Cartilage Repair Market Growth, by Procedure Type, Italy, 2011 - 2016
• Table 150: Knee Cartilage Repair Market, by Procedure Type, as a % of Total, Italy, 2010 - 2016
• Table 151: Knee Cartilage Repairs, by Procedure Type, Spain, 2010 - 2016
• Table 152: Knee Cartilage Repair Market, by Procedure Type, Spain (US$), 2010 - 2016
• Table 153: Knee Cartilage Repair Market, by Procedure Type, Spain (€ ), 2010 - 2016
• Table 154: Knee Cartilage Repair Market Growth, by Procedure Type, Spain, 2011 - 2016
• Table 155: Knee Cartilage Repair Market, by Procedure Type, as a % of Total, Spain, 2010 - 2016
• Table 156: Knee Cartilage Repairs, by Procedure Type, UK, 2010 - 2016
• Table 157: Knee Cartilage Repair Market, by Procedure Type, UK (US$), 2010 - 2016
• Table 158: Knee Cartilage Repair Market, by Procedure Type, UK (€ ), 2010 - 2016
• Table 159: Knee Cartilage Repair Market, by Procedure Type, UK (£), 2010 - 2016
• Table 160: Knee Cartilage Repair Market Growth, by Procedure Type, UK, 2011 - 2016
• Table 161: Knee Cartilage Repair Market, by Procedure Type, as a % of Total, UK, 2010 - 2016

APPENDIX B: MRG ACRONYMS AND INITIALISMS

• MRG Acronyms and Initialisms

APPENDIX C: BIBLIOGRAPHY

相關商品

生物材料相關市場調查報告書

口腔清潔用品&牙科用消耗品市場(牙科生技材料·特殊用途產品·修復劑):目前趨勢·市場機會·全球市場預測(∼2016年)
Oral Care Products & Other Dental Consumables Market (Dental Biomaterials, Specialty Products, & Restoratives) Current Trends, Opportunities & Global Forecasts to 2016
價格 : US $ 4650
出版日期 : 2012年04月

歐洲的牙科用人工骨替代材料，牙科再生膜及再生牙科市場(21個國家):2012年
European Markets for Dental Bone Graft Substitutes, Dental Membranes and Tissue Engineering 2012 (21 countries)
價格 : US $ 10995
出版日期 : 2012年03月

生物相容性材料的全球市場
Biocompatible Materials
價格 : US $ 4500
出版日期 : 2012年02月

Millennium Research Group發行的生物科技相關市場調查報告書

歐洲的整形外科用軟組織解決方案市場:2012年

European Markets for Orthopedic Soft Tissue Solutions 2012

價格 : US $ 5995

出版日期 : 2012年03月

亞洲的整形外科生醫材料市場:2012年

Asia Pacific Markets for Orthopedic Biomaterials

價格 : US $ 5995

出版日期 : 2011年12月

美國的外科用止血劑·組織內密封材料·防粘黏薄膜市場:2012年

US Markets for Surgical Hemostats, Internal Tissue Sealants, and Adhesion Barriers 2012

價格 : US $ 6995

出版日期 : 2011年11月

Email Alert(Email 通知) - 最新市場調查報告書

GII 將每天定期更新最新市場調查報書資訊，選擇您有興趣的市場分類，我們將用Email的方式讓您收到最新訊息!